
Prediction of human serum concentration–time profiles of therapeutic monoclonal antibodies using common marmosets (Callithrix jacchus): Initial assessment with canakinumab, adalimumab, and bevacizumab
Key Word(キーワード):
common marmosets, prediction of human serum concentration-time profiles
Ayaka Tajiri1、Shogo Matsumoto1、Satoshi Maeda2、Takuma Soga2、Kensuke Kagiyama2、Hiroshi Ikeda3、Kazumasa Fukasawa2、Atsunori Miyata1、Hidetaka Kamimura4
1Drug Discovery Department, R&D Division, Meiji Seika Pharma Co., Ltd., Tokyo, Japan.、2Yaotsu Breeding Center, CLEA Japan, Inc, Gifu, Japan.、3Tokyo Animal and Diet Department, CLEA Japan, Inc, Tokyo, Japan.、4Business Promotion Department, CLEA Japan, Inc, Tokyo Japan.
For more details, please click here (Google Search)
- Taylor & Francis
- July 10, 2024
Related CLEA Japan product: Marmoset
For the animal model, please click here ▼
https://www.clea-japan.com/en/products/various_animal/item_a0550
https://www.clea-japan.com/products/various_animal/item_a0550
Inquiry(お問い合わせ)
If you have any questions, please feel free to contact us.